Trademark: 79340988
Word
NRAVEL
Status
Registered
Status Code
700
Status Date
Tuesday, December 5, 2023
Serial Number
79340988
Registration Number
7232511
Registration Date
Tuesday, December 5, 2023
Mark Type
4
Filing Date
Monday, August 23, 2021
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Indivumed GmbH - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample materials, for medical purposes, namely, tumor tissues and tissue grafts samples, blood, serum, plasma, urine, stools, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; test kits of human and animal sample materials, comprising diagnostic reagents for medical purposes, namely, human and animal allograft and xenograft tissue, tissue cuts being biological tissue grafts and biological tissue cultures, blood plasma, blood serum, ascites being bodily fluids, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods, for medical use for the treatment of cancer; biological material collections, namely, biological tissue cultures for medical purposes; cancer material collections, namely, biological tissue being resected and biopsy tumor and adjacent non-tumor tissue from the human body including epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; medical sample collections, namely, biological tissue cultures for medical purposes; biological sample collections from the human body, namely, epithelial, connective, muscular, and nervous tissues, blood, serum, plasma, urine, stools for medical purposes; biopsy material collections, namely, biological tissue in the nature of blood, biological tissue grafts and biological tissue cultures for medical purposes; all the afore-mentioned in particular with regard to the field of oncology
44 Medical analyses in connection with the treatment of individuals including medical analysis of X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biology, for patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centres, namely, collecting and stabilizing of human and animal biospecimens, providing advice related thereto, and the collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology
42 Collection of clinical data for medical research and development of therapeutics and diagnostics; collecting genetic, medical, biomedical, biologic, chemical and biochemical data and information, in particular information generated through the use of imaging techniques, the use of liquid biopsy methods, the use of histopathological analysis and procedures, the use of genetic analysis and the use of genomics, proteomics, transcriptomics, metabolomics, lipidomics and/or glycomics studies and analysis for medical research; scientific and technological services, namely, research, design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, namely, molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods for research purposes; preparation of human and animal biospecimen for research purposes; providing information and data relating to medical and veterinary research on human and animal biospecimen, in particular genomic, epigenomic, proteomic, phosphoproteomic, RNA, transcriptomic, lipidomic and metabolomic data; medical laboratory services for medical research purposes, other than for diagnostic or treatment purposes, namely, typing of tissue and tissue samples, in particular using molecular biological, immunological, genetic engineering and histological methods; database design and development; software as a service (SAAS) services, namely, hosting software for use by others for use as a database; installation, maintenance and updating of database software; providing scientific research information and results from an online searchable database; programming of computer software for databases; scientific and laboratory analysis using bioinformatics and computational biology in the field of oncology; all the afore-mentioned in particular with regard to the field of oncology
In statement Class 42, has been updated in accordance with the F-note dated 03/08/2024.
N RAVEL

Trademark Events
May 19, 2022
Sn Assigned For Sect 66a Appl From Ib
May 23, 2022
New Application Office Supplied Data Entered
May 25, 2022
Assigned To Examiner
May 27, 2022
Application Filing Receipt Mailed
May 27, 2022
Non-Final Action Written
May 28, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 22, 2022
Refusal Processed By Mpu
Jun 23, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 13, 2022
Refusal Processed By Ib
Dec 7, 2022
Correction Created For Ib
Dec 7, 2022
Correction Created For Ib
Dec 7, 2022
Correction Sent To Ib
Dec 7, 2022
Correction Sent To Ib
Dec 21, 2022
Teas Response To Office Action Received
Dec 21, 2022
Correspondence Received In Law Office
Dec 21, 2022
Teas/Email Correspondence Entered
Jan 26, 2023
Non-Final Action Written
Jan 26, 2023
Non-Final Action E-Mailed
Jan 26, 2023
Notification Of Non-Final Action E-Mailed
Feb 28, 2023
Refusal Processed By Ib
Jul 24, 2023
Teas Response To Office Action Received
Jul 24, 2023
Correspondence Received In Law Office
Jul 25, 2023
Teas/Email Correspondence Entered
Aug 11, 2023
Examiners Amendment -Written
Aug 11, 2023
Examiners Amendment E-Mailed
Aug 11, 2023
Notification Of Examiners Amendment E-Mailed
Aug 11, 2023
Examiner's Amendment Entered
Aug 11, 2023
Approved For Pub - Principal Register
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 30, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 30, 2023
Notification Of Possible Opposition Sent To Ib
Sep 19, 2023
Published For Opposition
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2023
Notification Processed By Ib
Oct 25, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 25, 2023
Notification Of Possible Opposition Sent To Ib
Oct 30, 2023
Correction Transaction Received From Ib
Oct 30, 2023
Uspto Correction Processed By Ib
Nov 12, 2023
Notification Of Possible Opposition - Processed By Ib
Dec 5, 2023
Registered-Principal Register
Dec 5, 2023
Notice Of Registration Confirmation Emailed
Mar 5, 2024
Final Disposition Notice Created, To Be Sent To Ib
Mar 13, 2024
Correction Under Section 7 - Processed
Mar 14, 2024
Final Disposition Processed
Mar 14, 2024
Correction From Ib Entered - No Review Required
Mar 14, 2024
Final Disposition Notice Sent To Ib
Apr 8, 2024
Final Decision Transaction Processed By Ib
Apr 23, 2024
Notice Of Updated Registration Confirmation Emailed
May 14, 2024
Uspto Correction Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24